点评详情
发布于:2019-1-9 11:32:07  访问:34 次 回复:0 篇
版主管理 | 推荐 | 删除 | 删除并扣分
Ic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J Discomfort. 2016. [Epub
Simard6, Qiang Liu1,7 and Junwei Hao1*AbstractBackground: Non euronal acetylcholine (ACh) restricts autoimmune responses and attenuates inflammation by cholinergic anti-inflammation pathway. To date, the Tubacin HDAC implication of ACh in myasthenia gravis (MG) remained unexplored. This study aimed to investigate the attainable connection involving ACh levels, anti ValspodarTechnical Information uscle-specific tyrosine kinase (MuSK) antibody titers, most important clinical features and outcomes of MG individuals. Procedures: We effectively measured ACh levels in human peripheral blood mononuclear cells (PBMCs) from 125 MG sufferers and 50 matched healthy controls by utilizing ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). We assessed the quantitative MG (QMG) scores for every patient and titered anti-MuSK antibody. Results: We found that PBMC-derived ACh level was substantially larger PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26780312 in MG patients, particularly in patients of class III, IV-V, compared with that in controls (0.142 ?0.108 vs. 0.075 ?0.014 ng/million cells, p = 0.0003) in line with the Myasthenia Gravis Foundation of America clinical classification. Importantly, we also identified that ACh levels had been positively correlated with QMG scores (r = 0.83, p < 0.0001) and anti uSK Ab levels (r = 0.85, p < 0.0001). Conclusions: Our demonstration of elevated ACh levels in PBMCs of MG patients foreshadows potential new avenues for MG research and treatment. Keywords: Acetylcholine, Myasthenia gravis, Inflammation, Cholinergic anti-inflammatory pathwayBackground Myasthenia gravis (MG) is a well-recognized autoimmune disorder affecting neuromuscular junction [1, 2]. Inflammatory environment plays a crucial role in the progress of this disease [3], appropriate interference with inflammation is a very promising therapeutic strategy and PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26162776 needs additional study. Lately, research regarding the immune-modulating properties of acetylcholine (ACh) derived from nonneuronal cells has prompted an escalating interest within the field with the cholinergic anti-inflammatory pathway. Interestingly, non-neuronal ACh and major elements on the cholinergic technique, for example choline acetyltransferase (ChAT), acetylcholinesterase (AChE), vesicular acetylcholine transporter (VAChT) and high-affinity choline transporter* Correspondence: hjw@tmu.edu.cn 1 Department of Neurology, Tianjin Neurological Institute,.Ic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study. J Pain. 2016. [Epub ahead of print]. 17. Vinik EJ, Hayes RP, Oglesby A, et al. The development and validation from the Norfolk QOL-DN, a new measure of patients‘ perception with the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther. 2005;7:497?08. 18. Astellas Pharma Ltd. QUTENZATM 179 mg cutaneous patch SPC (2015). Readily available at https://www.medicines.org.uk/emc/medicine/23156. Accessed 4 Apr 2016.Submit your next manuscript to BioMed Central and we‘ll assist you at each and every step:?We accept pre-submission inquiries ?Our selector tool helps you to locate by far the most relevant journal ?We provide round the clock consumer assistance ?Hassle-free online submission ?Thorough peer critique ?Inclusion in PubMed and all important indexing solutions ?Maximum visibility for your analysis Submit your manuscript at www.biomedcentral.com/submit
Han et al. BMC Neurology (2017) 17:28 DOI ten.1186/s12883-016-0772-RESEARCH ARTICLEOpen AccessNon-neuronal cholinergic activity is potentiated in myasthenia gravisBin Han1, Chao Zhang1, Shoufeng Liu2, Yiping Xia3, Hao Sun4, Zhongying Gong5, Alain R.
共0篇回复 每页10篇 页次:1/1
共0篇回复 每页10篇 页次:1/1
我要回复
回复内容
验 证 码
看不清?更换一张
匿名发表 
当前位置
脚注信息

美博梁sir2010-2017版权所有